Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro

American Journal of Respiratory and Critical Care Medicine

Volumn 169, Issue 8, 2004, Pages 903-909

  Blanchet, Marie Renée ^a   Israël Assayag, Evelyne ^a   Cormier, Yvon ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Alveolar macrophages; Cytokines; Hypersensitivity pneumonitis; Nicotine

Indexed keywords

B7 ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA; NICOTINE; TUMOR NECROSIS FACTOR;

ALLERGIC PNEUMONITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; FEMALE; GENE EXPRESSION; INCIDENCE; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SACCHAROPOLYSPORA; SACCHAROPOLYSPORA RECTIVIRGULA; SMOKING;

EID: 1842503006     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200210-1154oc     Document Type: Article

References (27)

1. Katzung BG. Basic and clinical pharmacology. New York: McGraw-Hill/ Appleton & Lange; 1998.
2. Kalra R, Singh SP, Savage SM, Finch GL, Sopori ML. Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IPS-sensitive Ca(2+) stores. J Pharmacol Exp Ther 2000;293:166-171.
3. Payne JB, Johnson GK, Reinhardt RA, Dyer JK, Maze CA, Dunning DG. Nicotine effects on PGE2 and IL-1 beta release by LPS-treated human monocytes. J Periodontal Res 1996;31:99-104.
4. Matsunaga K, Klein TW, Friedman H, Yamamoto Y. Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 2001;167:6518-6524.
5. Zhang S, Petro TM. The effect of nicotine on murine CD4 T cell responses. Int J Immunopharmacol 1996;18:467-478.
6. Lahmouzi J, Simain-Sato F, Defresne MP, De Pauw MC, Heinen E, Grisar T, Legros JJ, Legrand R. Effect of nicotine on rat gingival fibroblasts in vitro. Connect Tissue Res 2000;41:69-80.
7. Louvet B, Buisine MP, Desreumaux P, Tremaine WJ, Aubert JP, Porchet N, Capron M, Cortot A, Colombel JF, Sandborn WJ. Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in ulcerative colitis. Inflamm Bowel Dis 1999;5: 174-181.
8. Mabley JG, Pacher P, Southan GJ, Salzman AL, Szabo C. Nicotine reduces the incidence of type I diabetes in mice. J Pharmacol Exp Ther 2002;300:876-881.
9. Warren CP. Extrinsic allergic alveolitis: a disease commoner in non-smokers. Thorax 1977;32:567-569.
10. Johansson S, Bjermer L, Franzen L, Henriksson R. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother Oncol 1998; 49:41-47.
11. Cormier Y, Israel-Assayag E, Bedard G, Duchaine C. Hypersensitivity pneumonitis in peat moss processing plant workers. Am J Respir Crit Care Med 1998;158:412-417.
12. Ohtsuka Y, Munakata M, Tanimura K, Ukita H, Kusaka H, Masaki Y, Doi I, Ohe M, Amishima M, Homma Y. Smoking promotes insidious and chronic farmer's lung disease, and deteriorates the clinical outcome. Intern Med 1995;34:966-971.
13. Sharma OP, Fujimura N. Hypersensitivity pneumonitis: a noninfectious granulomatosis. Semin Respir Infect 1995;10:96-106.
14. Fink JN. Hypersensitivity pneumonitis. J Allergy Clin Immunol 1984; 74:1-10.
15. Israel-Assayag E, Fournier M, Cormier Y. Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis. J Immunol 1999;163:6794-6799.
16. Schaaf BM, Seitzer U, Pravica V, Aries SP, Zabel P. Tumor necrosis factor-alpha-308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients. Am J Respir Crit Care Med 2001;163:379-382.
17. Gudmundsson G, Bosch A, Davidson BL, Berg DJ, Hunninghake GW. Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice. Am J Respir Cell Mol Biol 1998;19:812-818.
18. Gudmundsson G, Hunninghake GW. Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest 1997;99: 2386-2390.
19. Israel-Assayag E, Dakhama A, Lavigne S, Laviolette M, Cormier Y. Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1999;159: 1830-1834.
20. Blanchet M-R, Israel-Assayag E, Cormier Y. Nicotine and the cellular immune response in hypersensitivity pneumonitis (HP) (abstract). Am J Respir Crit Care Med 2001;A748.
21. Benowitz NL, Jacob P III. Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther 1984;35:499-504.
22. Guthrie SK, Zubieta JK, Ohl L, Ni L, Koeppe RA, Minoshima S, Domino EF. Arterial/venous plasma nicotine concentrations following nicotine nasal spray. Eur J Clin Pharmacol 1999;55:639-643.
23. Mellon RD, Bayer BM. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses. J Pharmacol Exp Ther 1999;288:635-642.
24. Sykes AP, Brampton C, Klee S, Chander CL, Whelan C, Parsons ME. An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease. Inflamm Res 49:311-319.
25. Madretsma S, Wolters LM, van Dijk JP, Tak CJ, Feyerabend C, Wilson JH, Zijlstra FJ. In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells. Eur J Gastroenterol Hepatol 1996;8:1017-1020.
26. Dobrovolskaia MA, Vogel SN. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 2002;4:903-914.
27. Yamasaki H, Ando M, Brazer W, Center DM, Cruikshank WW. Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis. J Immunol 1999;163:3516-3523.